| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD010488.PUB2 |
| P8608 | Fatcat ID | release_wnzbu5eobrft3bbpddzhyxb2bq |
| P50 | author | Christian Gluud | Q26265142 |
| P2093 | author name string | Christian H Møller | |
| Daniel A Steinbrüchel | |||
| Lars Søndergaard | |||
| Hans GH Thyregod | |||
| P2860 | cites work | Industry sponsorship and research outcome | Q24202591 |
| Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis | Q24289436 | ||
| Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study | Q24653790 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Development of transcatheter aortic valve implantation (TAVI): A 20-year odyssey | Q27004581 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
| How should meta-regression analyses be undertaken and interpreted? | Q28193388 | ||
| Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description | Q28216985 | ||
| Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses | Q29619185 | ||
| Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Q29619328 | ||
| What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data | Q30926358 | ||
| The natural history of aortic valve stenosis | Q33169026 | ||
| Spontaneous course of aortic valve disease | Q33169649 | ||
| Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system | Q33194872 | ||
| Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement | Q33487003 | ||
| Estimating required information size by quantifying diversity in random-effects model meta-analyses. | Q33521365 | ||
| Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry | Q34054341 | ||
| Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study | Q34418948 | ||
| Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium | Q34492675 | ||
| Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients | Q34637935 | ||
| Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document | Q34644302 | ||
| 5-year outcome after transcatheter aortic valve implantation. | Q34646784 | ||
| 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Commit | Q34838596 | ||
| The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery | Q34989376 | ||
| Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies | Q36169078 | ||
| Bias in clinical intervention research. | Q36380552 | ||
| Genetic associations with valvular calcification and aortic stenosis | Q37154922 | ||
| Percutaneous transarterial aortic valve implantation: what do we know? | Q37816070 | ||
| Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study | Q37822524 | ||
| Meta‐analysis of complications in aortic valve replacement: Comparison of Medtronic‐Corevalve, Edwards‐Sapien and surgical aortic valve replacement in 8,536 patients | Q37993494 | ||
| Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis | Q38040764 | ||
| Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies | Q38044510 | ||
| Left ventricular systolic function in aortic stenosis | Q39486826 | ||
| EuroSCORE II. | Q39646373 | ||
| Guidelines on the management of valvular heart disease (version 2012). | Q40276570 | ||
| Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome | Q40894486 | ||
| Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention | Q41952217 | ||
| Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries | Q42665115 | ||
| Aortic valve replacement in octogenarians: identification of high-risk patients | Q43179530 | ||
| Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial | Q43202673 | ||
| Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). | Q43423750 | ||
| Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis | Q43638006 | ||
| Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation | Q43794118 | ||
| Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis | Q43809900 | ||
| Transcatheter aortic valve implantation: first results from a multi-centre real-world registry | Q43817304 | ||
| Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction | Q43960931 | ||
| Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates | Q44275410 | ||
| Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience | Q44596208 | ||
| Natural history of very severe aortic stenosis. | Q44637628 | ||
| Cardiac valve surgery in octogenarians: improving quality of life and functional status | Q46451268 | ||
| Current determinants of operative mortality in 1400 patients requiring aortic valve replacement | Q47782768 | ||
| A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease | Q47797002 | ||
| Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up | Q47877526 | ||
| Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study | Q48296883 | ||
| One-year results of health-related quality of life among patients undergoing transcatheter aortic valve implantation | Q48452689 | ||
| Natural history of aortic valve stenosis of varying severity in the elderly | Q51022337 | ||
| Transapical transcatheter aortic valve implantation: follow-up to 3 years | Q51569728 | ||
| Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database | Q51661996 | ||
| A comparison of methods to detect publication bias in meta-analysis | Q52067551 | ||
| European system for cardiac operative risk evaluation (EuroSCORE). | Q52174977 | ||
| Effect of Experience on Results of Transcatheter Aortic Valve Implantation Using a Medtronic CoreValve System | Q57293611 | ||
| Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? | Q57780007 | ||
| Cerebral Embolism Following Transcatheter Aortic Valve Implantation | Q57785471 | ||
| Aortic Valve Replacement in Octogenarians: Utility of Risk Stratification With EuroSCORE | Q57915744 | ||
| Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis | Q58071725 | ||
| Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly | Q59077016 | ||
| Burden of valvular heart diseases: a population-based study | Q61663367 | ||
| Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs | Q68183608 | ||
| The effect of aortic valve replacement on survival | Q70475903 | ||
| Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis | Q70529367 | ||
| Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval | Q83098264 | ||
| 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis | Q83862969 | ||
| Transapical aortic valve implantation in Rouen: Four years’ experience with the Edwards transcatheter prosthesis | Q83946287 | ||
| Long-term survival after aortic valve replacement in octogenarians and high-risk subgroups | Q84058640 | ||
| Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era | Q84061183 | ||
| Transcatheter aortic valve implantation transapical: step by step | Q84635018 | ||
| P921 | main subject | aortic valve stenosis | Q531019 |
| P577 | publication date | 2015-08-14 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Transcatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosis |
Search more.